Literature DB >> 18253701

Hierarchical QSAR technology based on the Simplex representation of molecular structure.

V E Kuz'min1, A G Artemenko, E N Muratov.   

Abstract

This article is about the hierarchical quantitative structure-activity relationship technology (HiT QSAR) based on the Simplex representation of molecular structure (SiRMS) and its application for different QSAR/QSP(property)R tasks. The essence of this technology is a sequential solution (with the use of the information obtained on the previous steps) to the QSAR problem by the series of enhanced models of molecular structure description [from one dimensional (1D) to four dimensional (4D)]. It is a system of permanently improved solutions. In the SiRMS approach, every molecule is represented as a system of different simplexes (tetratomic fragments with fixed composition, structure, chirality and symmetry). The level of simplex descriptors detailing increases consecutively from the 1D to 4D representation of the molecular structure. The advantages of the approach reported here are the absence of "molecular alignment" problems, consideration of different physical-chemical properties of atoms (e.g. charge, lipophilicity, etc.), the high adequacy and good interpretability of obtained models and clear ways for molecular design. The efficiency of the HiT QSAR approach is demonstrated by comparing it with the most popular modern QSAR approaches on two representative examination sets. The examples of successful application of the HiT QSAR for various QSAR/QSPR investigations on the different levels (1D-4D) of the molecular structure description are also highlighted. The reliability of developed QSAR models as predictive virtual screening tools and their ability to serve as the base of directed drug design was validated by subsequent synthetic and biological experiments, among others. The HiT QSAR is realized as a complex of computer programs known as HIT QSAR: software that also includes a powerful statistical block and a number of useful utilities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253701     DOI: 10.1007/s10822-008-9179-6

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  25 in total

Review 1.  Soft drug design: general principles and recent applications.

Authors:  N Bodor; P Buchwald
Journal:  Med Res Rev       Date:  2000-01       Impact factor: 12.944

Review 2.  Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry.

Authors:  F Ooms
Journal:  Curr Med Chem       Date:  2000-02       Impact factor: 4.530

3.  The analysis of structure-anticancer and antiviral activity relationships for macrocyclic pyridinophanes and their analogues on the basis of 4D QSAR models (simplex representation of molecular structure).

Authors:  Victor E Kuz'min; Anatoly G Artemenko; Victor P Lozitsky; Eugene N Muratov; Alla S Fedtchouk; Natalia S Dyachenko; Lidiya N Nosach; Tatiyana L Gridina; Larisa I Shitikova; Liubov M Mudrik; Aleksey K Mescheriakov; Vladislav A Chelombitko; Andrey I Zheltvay; Jean-Jaques Vanden Eynde
Journal:  Acta Biochim Pol       Date:  2002       Impact factor: 2.149

4.  Modeling aqueous solubility.

Authors:  Darko Butina; Joelle M R Gola
Journal:  J Chem Inf Comput Sci       Date:  2003 May-Jun

5.  Antirhinoviral activity of heterocyclic analogs of Win 54954.

Authors:  T R Bailey; G D Diana; P J Kowalczyk; V Akullian; M A Eissenstat; D Cutcliffe; J P Mallamo; P M Carabateas; D C Pevear
Journal:  J Med Chem       Date:  1992-11-27       Impact factor: 7.446

6.  A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES.

Authors:  S M FREE; J W WILSON
Journal:  J Med Chem       Date:  1964-07       Impact factor: 7.446

7.  Structure based activity prediction of HIV-1 reverse transcriptase inhibitors.

Authors:  Marc R de Jonge; Lucien M H Koymans; H Maarten Vinkers; Frits F D Daeyaert; Jan Heeres; Paul J Lewi; Paul A J Janssen
Journal:  J Med Chem       Date:  2005-03-24       Impact factor: 7.446

8.  Investigation of anticancer activity of macrocyclic Schiff bases by means of 4D-QSAR based on simplex representation of molecular structure.

Authors:  V E Kuz'min; A G Artemenko; R N Lozytska; A S Fedtchouk; V P Lozitsky; E N Muratov; A K Mescheriakov
Journal:  SAR QSAR Environ Res       Date:  2005-06       Impact factor: 3.000

Review 9.  Chemical Toxicity on HeLa Cells.

Authors:  Rajeshwar P Verma; Corwin Hansch
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

10.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

View more
  32 in total

1.  Predictive modeling of chemical hazard by integrating numerical descriptors of chemical structures and short-term toxicity assay data.

Authors:  Ivan Rusyn; Alexander Sedykh; Yen Low; Kathryn Z Guyton; Alexander Tropsha
Journal:  Toxicol Sci       Date:  2012-03-02       Impact factor: 4.849

2.  QSAR modeling: where have you been? Where are you going to?

Authors:  Artem Cherkasov; Eugene N Muratov; Denis Fourches; Alexandre Varnek; Igor I Baskin; Mark Cronin; John Dearden; Paola Gramatica; Yvonne C Martin; Roberto Todeschini; Viviana Consonni; Victor E Kuz'min; Richard Cramer; Romualdo Benigni; Chihae Yang; James Rathman; Lothar Terfloth; Johann Gasteiger; Ann Richard; Alexander Tropsha
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

3.  Chembench: A Publicly Accessible, Integrated Cheminformatics Portal.

Authors:  Stephen J Capuzzi; Ian Sang-June Kim; Wai In Lam; Thomas E Thornton; Eugene N Muratov; Diane Pozefsky; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2017-01-19       Impact factor: 4.956

4.  Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.

Authors:  Stephen J Capuzzi; Wei Sun; Eugene N Muratov; Carles Martínez-Romero; Shihua He; Wenjun Zhu; Hao Li; Gregory Tawa; Ethan G Fisher; Miao Xu; Paul Shinn; Xiangguo Qiu; Adolfo García-Sastre; Wei Zheng; Alexander Tropsha
Journal:  J Med Chem       Date:  2018-04-17       Impact factor: 7.446

5.  QSAR analysis of the toxicity of nitroaromatics in Tetrahymena pyriformis: structural factors and possible modes of action.

Authors:  A G Artemenko; E N Muratov; V E Kuz'min; N N Muratov; E V Varlamova; A V Kuz'mina; L G Gorb; A Golius; F C Hill; J Leszczynski; A Tropsha
Journal:  SAR QSAR Environ Res       Date:  2011-06-30       Impact factor: 3.000

6.  Structure-reactivity modeling using mixture-based representation of chemical reactions.

Authors:  Pavel Polishchuk; Timur Madzhidov; Timur Gimadiev; Andrey Bodrov; Ramil Nugmanov; Alexandre Varnek
Journal:  J Comput Aided Mol Des       Date:  2017-07-27       Impact factor: 3.686

7.  Predicting Adverse Drug Effects from Literature- and Database-Mined Assertions.

Authors:  Mary K La; Alexander Sedykh; Denis Fourches; Eugene Muratov; Alexander Tropsha
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

8.  Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compounds.

Authors:  Vinicius M Alves; Eugene Muratov; Denis Fourches; Judy Strickland; Nicole Kleinstreuer; Carolina H Andrade; Alexander Tropsha
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-03       Impact factor: 4.219

9.  Alarms about structural alerts.

Authors:  Vinicius Alves; Eugene Muratov; Stephen Capuzzi; Regina Politi; Yen Low; Rodolpho Braga; Alexey V Zakharov; Alexander Sedykh; Elena Mokshyna; Sherif Farag; Carolina Andrade; Victor Kuz'min; Denis Fourches; Alexander Tropsha
Journal:  Green Chem       Date:  2016-06-28       Impact factor: 10.182

10.  Predicting binding affinity of CSAR ligands using both structure-based and ligand-based approaches.

Authors:  Denis Fourches; Eugene Muratov; Feng Ding; Nikolay V Dokholyan; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2013-07-17       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.